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Abstract
Objectives. The impact of disease on functioning is the essential information for clinicians when reporting
on health problems of individuals. The International Classification of Functioning, Disability and Health
(ICF) is a comprehensive and universally accepted model to classify and describe functioning, disability
and health in a systematic way. The objective of this article is to outline the development and validation of
a health index for patients with AS based on the ICF as a use case.
Methods. The project is a combined effort of the Assessment of SpondyloArthritis International Society,
the ICF Research Branch of the World Health Organization (WHO) Collaboration Centre of the Family of
International Classifications and the WHO. There are five steps in the development and validation of the
health index for patients with AS: (i) development of an item pool; (ii) identification of candidate items;
(iii) item selection; (iv) item reduction; and (v) creation of a final version. Consensus about items that have
to be part will be reached in a final consensus conference.
Results. During a meeting in February 2009, we coordinated the development process of the health index
for patients with AS. The results of this investigation will be the health index for patients with AS.
Conclusion. The goal of developing a health index for patients with AS based on the ICF is very much in
line with the broader goal of the WHO to define health indices to ensure the comparability of them within
the framework of the ICF.
Key words: Ankylosing spondylitis, Functioning, Health status, Health status measures, International
Classification of Functioning, Disability and Health.
Introduction
AS, the main subgroup of the spondyloarthritides, is a
chronic inflammatory disease characterized by inflam-
mation and ankylosis of the axial skeleton [1]. Since AS
usually starts in early adulthood, the lifetime impact of AS
on patients can be considerable. Apart from symptoms
such as pain, stiffness and fatigue, patients are limited
in activities and restricted in participation in society.
Functioning is increasingly being taken into account in
assessing the impact of chronic diseases on the individual,
as well as the effectiveness of treatments. Functioning
is often referred to as function. However, it is import-
ant to realize that function is often limited to physical
function ignoring the complexity of global functioning.
With the approval of the International Classification of
Functioning, Disability and Health (ICF) by the World
Health Organization (WHO) there is now a universally
accepted model to classify and describe functioning,
disability and health in persons with all kind of diseases
or conditions in a more systematic way [2]. The ICF
allows clinicians to comprehensively describe and
categorize functioning and disability of their patients in a
way that can be understood by all health professionals. The
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ICF model identifies three components of the dimension of
functioning, namely body functions, body structures, as
well as activity and participation. To apply the ICF in prac-
tice, ICF Core Sets, which comprise specific categories
relevant for a particular condition, have been developed
for various diseases. Both a Brief ICF Core Set and a
Comprehensive ICF Core Set have been established for
patients with AS [3].
Clinicians often rely on summary scores that integrate
different aspects of functioning and which are usually con-
structed by adding up the responses to different items.
Summary scores allow clinicians to estimate the overall
level of functioning of patients, to monitor disease and
rehabilitation management, and to follow patients along
the continuum of care over the lifespan.
The objective of this article is to outline the development
and validation of a health index for patients with AS based
on the categorical profile built on the ICF Core Set for AS
as a use case.
Materials and methods
The development and validation of the health index for
patients with AS is a combined effort of the Assessment
of SpondyloArthritis International Society (ASAS), the ICF
Research Branch of the WHO Collaboration Centre of
the Family of International Classifications and the WHO.
This effort was coordinated in a meeting held in Zurich,
Switzerland on 26 February 2009. The following members
from the above outlined partners were involved: A.B., J.B.,
U.K., D.vdH. (all ASAS), A.C., G.S. (ICF Research Branch)
and B.U¨. (WHO). Starting points that were agreed upon
during this meeting and issues that have to be resolved at
a later stage are described in this article. All aspects of the
project will be conducted in conformity with the ethical
principles of the Declaration of Helsinki. The appropriate
study-related documents will be presented to the corres-
ponding ethics committees for review and approval.
Methodology
There will be five steps in the development and validation
of the health index for patients with AS. A summary of
the methodology of the preliminary surveys and of the
consensus meeting is shown in Table 1.
Methodology of the development
Preparatory phase (Phase I)
Selection of instruments. As a starting point we will
create an item pool covering the categories of the
Comprehensive and Brief ICF Core Set for AS [3].
The item pool will be collected from various instru-
ments currently available for use in patients with AS,
which focus on symptoms, functioning and composed
measures such as questionnaires about quality of
life (QoL). Questionnaires used should assesses differ-
ent aspects of patients with AS. The following instru-
ments have already been agreed upon during
the meeting in Zurich: ASQoL Questionnaire; BASFI;
Dougados Functional Index; EuroQoL-five dimensions
(EQ5D); Functional Assessment of Chronic Illness
Therapy-fatigue (FACIT-fatigue); HAQ modified for
SpAs (HAQ-S); Health Utilities Index-Mark 3 (HUI-3);
Hospital Anxiety and Depression Scale (HADS); Jenkins
Sleep Disorder; Nottingham Health Profile; Psoriatic
Arthritis QoL (PsAQoL) Questionnaire; RA-specific QoL
Instrument; Revised Leeds Disability Questionnaire;
Short-form 36; WHO Disability Assessment Schedule II;
Work Productivity; and Activity Impairment
Questionnaire General Health [419]. These question-
naires may not cover the whole spectrum of the ICF
Core Set for AS. In this case, we want to screen additional
instruments that are not commonly used in patients with
AS, but are already linked to the ICF (e.g. Daily Stress
Inventory) [20].
Linkage of instruments to the ICF. Some of these instru-
ments have been already linked and the results have been
published elsewhere [2125]. Items out of the following
instruments will be linked explicitly for this project:
FACIT fatigue, HUI-3, HADS, Jenkins Sleep Disorder and
PsAQoL. The items will be linked separately by two
trained health professionals (U.K. and A.B.) according
to established linking rules [26]. Consensus between the
two health professionals has to be reached. To resolve
disagreements between them concerning the selected
categories, a third person trained in the linking rules will
be consulted (A.C.).
Selection of items. Items of these instruments will be
selected for inclusion if they contain only one concept
and if the sentences are short and simple. A preliminary
estimate assumes that the item pool will consist of
150 items.
Adaptation of items. Each item will be adapted to the
following criteria: the items should be expressed in the
first person and in the present tense. As far as possible,
potential items will be direct quotations from the original
instruments.
TABLE 1 Summary of the methodology of the preliminary surveys and of the consensus meeting
Phase Objectives Methods
I. Preparatory phase Development of an item pool Linkage of various assessment tools to ICF
II. First postal survey Identification of candidate items Rasch analysis
III. Expert survey Item selection Nominal consensus process
IV. Second postal survey Validation of the draft version; Item reduction Testing psychometric properties; Rasch analysis
V. Consensus meeting Creation a final version Nominal consensus process
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Methodology of validation
First postal survey (Phase II)
The objective of this step is to identify items that differen-
tiate between persons with different levels of functioning.
The item pool will be studied in a multicentre,
cross-sectional study. The item pool will be split into
three different sets, which will be designed for 300
patients. Within the sets, there will be items that are simi-
lar in each set. These repeated items are considered
to reflect basic ideas such as pain or impaired mobility,
and therefore serve as comparators in the selection
process.
To identify candidate items the data set will be
subjected to Rasch analysis to assess the overall fit of
the model, individual item fit, the response scale used
and the presence of differential item functioning (DIF).
The fit of the data to the model is a prerequisite to con-
struct measures. DIF assesses the effect of external fac-
tors, such as gender or age, on individual item response. It
is important to demonstrate that items will not be valuated
differently by subgroups. Thus, a reduced item pool will
be evolved by removing items not fitting the model
expectations.
Expert survey (Phase III)
To confirm the content validity of the items selected in
Phase II, an expert survey will be performed. The steering
committee together with additional invited international
experts in the field of spondyloarthritis from most WHO
regions will produce a draft version by means of item
selection with a nominal consensus technique. In addition,
we will decide on the response format on the basis of the
results of the first postal survey and the results of the
Rasch analysis.
Second postal survey (Phase IV)
The objective of this step is to test scaling properties,
reliability, internal consistency and construct validity
of the draft version. In a multicentre, cross-sectional
study 250 AS patients will receive the draft version
together with a demographic questionnaire and additional
comparator measures (BASFI and HAQ-S). This package
will be sent twice, 2 weeks apart, short enough to
minimize change in condition over time, but long enough
to minimize memory of responses. Patients will be asked if
there has been a change in disease status between the
first and the second questionnaire. Data from this stage
will be fitted to the Rasch model to confirm that the
items form a unidimensional scale, that they represent
hierarchical ordering, and to confirm the absence of
DIF. After performance of Rasch analysis, a revised
version of the health index for patients with AS will be
available.
Consensus meeting (Phase V)
The objective of this step is to create a final version of the
health index for patients with AS. In a consensus meeting,
we will discuss controversial items. Agreement will be
achieved by a nominal consensus process.
Results
The results of this investigation will be the health index for
patients with AS.
Discussion
The increasing recognition of functioning and health has
led to an impressive effort in research to develop instru-
ments to measure them. The ICF as a common framework
for functioning is being increasingly applied in clinical
research and practice. A methodological exploration has
shown that it is possible to principally construct clinical
measures for patients with AS based on the ICF [27].
However, for the development of health indices basic re-
quirements have to be fulfilled. The members of the WHO
Functioning and Disability Reference Group are currently
discussing the components: (i) comparability, (ii) metric
equivalence and (iii) assessment of QoL.
(i) Comparability of diseases is requested for ranking
different diseases. Therefore, instruments should
contain generic items not specific to AS, which
will allow comparability between other diseases
than AS.
(ii) Metric equivalence is another prerequisite to be
able to compare different instruments. Instruments
with metric properties that provide summary scores
across a number of ICF categories would provide
clinicians with an understanding of patients’ overall
level of functioning.
(iii) Assessing QoL is important especially for patients
with chronic disabling conditions. In the absence
of a cure for the disease, information about QoL
provide evidence that therapy really makes people
feel better.
As shown in content comparison of health-related QoL
(HRQoL) instruments different aspects are scarcely repre-
sented within the instruments and many generic tools lack
the precision required for effective health care decision
making [23]. Based on this, ASAS started to develop an
index for measurement of health in patients with AS. The
aim of the ASAS Health Index is to cover all concepts of
functioning relevant to patients with AS. It has been
shown that only 50% of concepts important for function-
ing of patients with AS are covered by instruments
included in the core sets of outcomes for AS or other
disease-specific instruments [22]. Especially, aspects of
contextual factors (such as support, attitudes of family,
medication and financial assets) are not adequately
covered by standard measures. But the contribution of
contextual factors to functioning is important. Goordeev
et al. [28] showed that contextual factors explained 37 and
47% of the variance in EQ5D and ASQoL, respectively,
which is in line with the finding by Dagfinrud et al. [29] that
impairment variables (disease activity and pain) explained
only one-third of activity and participation restrictions.
As in any scientific endeavour, there are uncertainties
that have to be resolved during the development process.
As mentioned, inconsistencies in linking ICF items have
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been shown in former procedures and are likely to occur
within the development process of the health index.
The fact that the concepts, health status, functional
status, QoL and HRQoL, are often applied interchange-
ably in the literature is less irritating when the measures for
which those concepts are applied are linked to the ICF.
Since HRQoL and ICF represent two different perspec-
tives from which to look at functioning and health, it is
expected that both will often be used concurrently.
The goal of developing a health index for a specific
condition based on the ICF and its Core sets is very
much in line with the broader goal of the WHO to define
health indices with the above outlined basic requirements
of instruments to ensure the comparability of them within
the framework of the ICF.
Rheumatology key messages
. Functioning is an important aspect in patients with
chronic diseases.
. Valid disease-specific instruments are needed to
describe functioning based on the ICF.
. We described the process of instrument selection
and adaptation of items.
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